The forecast for hospital discharges for dermatitis, eczema, and papulosquamous disorders in Canada from 2024 to 2028 shows stability at 1.69 thousand cases annually, with a slight increase to 1.7 thousand in 2028. In 2023, the number of discharges stood at a similar level, suggesting consistent demand for medical services related to these conditions. Over these forecasted years, the compound annual growth rate (CAGR) remains relatively flat, indicating minimal variations year-on-year.
Looking towards the future, factors such as advancements in treatment options, changes in population demographics, and potential improvements in preventive healthcare practices could influence hospitalization rates. Furthermore, any shifts in healthcare policy or public awareness campaigns targeting skin health could either reduce or necessitate further hospitalizations for these conditions.
